Nothing was found on your request

drugs pharmaceuticals

Veterans Agency to Offer New Depression Drug, Despite Cost and Safety Concerns

Veterans Agency to Offer New Depression Drug, Despite Cost and Safety Concerns

The agency is struggling to contain rising rates of suicide among veterans.
Veterans Agency to Offer New Depression Drug, Despite Cost and Safety Concerns

Veterans Agency to Offer New Depression Drug, Despite Cost and Safety Concerns

The agency is struggling to contain rising rates of suicide among veterans.
Veterans Agency to Offer New Depression Drug, Despite Cost and Safety Concerns

Veterans Agency to Offer New Depression Drug, Despite Cost and Safety Concerns

The agency is struggling to contain rising rates of suicide among veterans.
Veterans Agency to Offer New Depression Drug, Despite Cost and Safety Concerns

Veterans Agency to Offer New Depression Drug, Despite Cost and Safety Concerns

The agency is struggling to contain rising rates of suicide among veterans.
New Sex Drug for Women to Improve Low Libido Is Approved by the F.D.A.

New Sex Drug for Women to Improve Low Libido Is Approved by the F.D.A.

The treatment involves an injectable pen and can cause nausea. Only one other ‘Viagra for women’ therapy is on the market.
New Sex Drug for Women to Improve Low Libido Is Approved by the F.D.A.

New Sex Drug for Women to Improve Low Libido Is Approved by the F.D.A.

The treatment involves an injectable pen and can cause nausea. Only one other ‘Viagra for women’ therapy is on the market.
New Sex Drug for Women to Improve Low Libido Is Approved by the F.D.A.

New Sex Drug for Women to Improve Low Libido Is Approved by the F.D.A.

The treatment involves an injectable pen and can cause nausea. Only one other ‘Viagra for women’ therapy is on the market.
New Sex Drug for Women to Improve Low Libido Is Approved by the F.D.A.

New Sex Drug for Women to Improve Low Libido Is Approved by the F.D.A.

The treatment involves an injectable pen and can cause nausea. Only one other ‘Viagra for women’ therapy is on the market.
New Sex Drug for Women to Improve Low Libido Is Approved by the F.D.A.

New Sex Drug for Women to Improve Low Libido Is Approved by the F.D.A.

The treatment involves an injectable pen and can cause nausea. Only one other ‘Viagra for women’ therapy is on the market.

‘Medicare for All’ vs. ‘Public Option’: The 2020 Field Is Split, Our Survey Shows

We asked the Democratic presidential candidates how they would improve the health care system. Some want to eliminate private insurance, but many others said that was a step too far.

‘Medicare for All’ vs. ‘Public Option’: The 2020 Field Is Split, Our Survey Shows

We asked the Democratic presidential candidates how they would improve the health care system. Some want to eliminate private insurance, but many others said that was a step too far.
Drug Companies Are Focusing on the Poor After Decades of Ignoring Them

Drug Companies Are Focusing on the Poor After Decades of Ignoring Them

The pharmaceutical industry once sued to keep AIDS drugs from dying Africans. Now companies boast of their efforts to get medicines to the developing world.
Drug Companies Are Focusing on the Poor After Decades of Ignoring Them

Drug Companies Are Focusing on the Poor After Decades of Ignoring Them

The pharmaceutical industry once sued to keep AIDS drugs from dying Africans. Now companies boast of their efforts to get medicines to the developing world.
Drug Companies Are Focusing on the Poor After Decades of Ignoring Them

Drug Companies Are Focusing on the Poor After Decades of Ignoring Them

The pharmaceutical industry once sued to keep AIDS drugs from dying Africans. Now companies boast of their efforts to get medicines to the developing world.
Drug Companies Are Focusing on the Poor After Decades of Ignoring Them

Drug Companies Are Focusing on the Poor After Decades of Ignoring Them

The pharmaceutical industry once sued to keep AIDS drugs from dying Africans. Now companies boast of their efforts to get medicines to the developing world.
Botox Maker Allergan Is Sold to AbbVie in $63 Billion Deal

Botox Maker Allergan Is Sold to AbbVie in $63 Billion Deal

The transaction would give AbbVie a potent source of popular treatments as it faces the loss of patent protection for its best-selling drug, Humira.
Botox Maker Allergan Is Sold to AbbVie in $63 Billion Deal

Botox Maker Allergan Is Sold to AbbVie in $63 Billion Deal

The transaction would give AbbVie a potent source of popular treatments as it faces the loss of patent protection for its best-selling drug, Humira.
Botox Maker Allergan Is Sold to AbbVie in $63 Billion Deal

Botox Maker Allergan Is Sold to AbbVie in $63 Billion Deal

The transaction would give AbbVie a potent source of popular treatments as it faces the loss of patent protection for its best-selling drug, Humira.
Botox Maker Allergan Is Sold to AbbVie in $63 Billion Deal

Botox Maker Allergan Is Sold to AbbVie in $63 Billion Deal

The transaction would give AbbVie a potent source of popular treatments as it faces the loss of patent protection for its best-selling drug, Humira.
Drug Companies Are Focusing on the Poor After Decades of Ignoring Them

Drug Companies Are Focusing on the Poor After Decades of Ignoring Them

The pharmaceutical industry once sued to keep AIDS drugs from dying Africans. Now companies boast of their efforts to get medicines to the developing world.